Note: Descriptions are shown in the official language in which they were submitted.
CA 02273514 1999-06-02
BLOOD CLOT DETECTOR
BACKGROUND OF THE INVENTION
This invention relates to an apparatus and method for detecting pipette tip
obstructions and more particularly to a method and apparatus for detecting a
blood clot
obstruction at a pipette during aspiration of a blood sample for sample
analysis.
In known automatic sampling systems, predetermined test sample volumes of
blood
or serum react with predetermined volumes of reagent to produce a measurable
test result
that is the basis for an analytical determination of blood characteristics.
Known sampling
systems usually include a pipette or sampling probe to aspirate test sample
from a
container such as a tube or cuvette.
If the pipette aspirates less than the predetermined test sample volume a
flawed test
result can occur since accurate test results require a predetermined test
sample volume to
react with a predetermined amount of reagent. As with many analytical
processes a limited
volumetric difference from the predetermined test sample volume may be
tolerable for test
purposes.
The volume of aspirated test sample can be predetermined when the aspiration
occurs over a known time duration since the tip opening of the pipette is
known and the
aspiration flow rate of test sample into the pipette is known from the
operational
characteristics of the aspiration pump. Thus the aspiration of test sample is
usually time
controlled with the aspiration time corresponding to a predetermined volume of
aspirated
test sample.
It is also known that a blood sample in a container may contain a clot or
clots and
that such clots can close or obstruct the probe tip, impeding the aspiration.
If movement of
CA 02273514 1999-06-02
fluid into the probe is fully or partially blocked during a fixed aspiration
time cycle a
reduced volume of test sample will be aspirated. In some instances a clot or
obstruction
remains in the flow path of fluid directed into the probe and never clogs the
probe.
Nevertheless a flow path obstruction can also reduce the flow rate of fluid
aspirated in a
given time, thus preventing the aspirated test sample from reaching the
predetermined
volume in the preset aspiration time.
In other instances a clot or obstruction will enter and clog the probe,
thereby
reducing the flow rate of fluid being aspirated and preventing the
predetermined volume of
fluid from being aspirated in a preset aspiration time. Subsequent aspirations
by the
clogged probe will also be less than the expected predetermined sample volume.
Since a
limited volumetric difference from the predetermined test sample volume may be
acceptable for test purposes, it is desirable to provide a system and method
that
distinguishes between acceptable aspiration volumes and unacceptable
aspiration volumes.
Previous attempts to detect clot obstructed aspirations are generally based on
a
detection of pressure conditions during aspiration. For example, U.S. Patent
5,503,036 to
N~uyen et al shows an obstruction detection circuit with a pressure sensor to
detect
abnormal pressure conditions in a sample probe. The abnormal pressure
conditions signify
the presence of an obstruction.
U.S. Patent 3,754,444 to Ure et al shows a medical sampling device that
includes a
clot detector that relies on a pressure increase in the fluid system to set
off an alarm.
European Publication 0289946A2 to Itoh shows a pressure switch to detect
pipette
clogging. European Publication 0571100A1 to Tolonen shows a pressure
transducer to
2
CA 02273514 1999-06-02
detect pipette clogging. European Publication 0658769A1 to Takeda et al shows
the use of
pressure readings to detect a leakage condition in a pipette.
In most known blood clot detection systems the sample volume aspirated is
relatively large, such as for example, approximately 200 microliters.
Aspiration of a 200
microliter sample usually provides recognizable vacuum measurements in the
aspiration
line that can be detected by a pressure transducer or other pressure sensing
device. A
vacuum measurement that is made under normal unobstructed aspiration
conditions can be
used as a reference standard. Vacuum measurements are then made for each test
sample
aspiration and any deviation from the reference standard by a predetermined
amount can
indicate an obstructed aspiration. An appropriate warning signal can be
generated in
response to a deviant vacuum measurement to alert an operator that an
obstructed probe
condition has been detected.
Unless otherwise indicated the term "clot detection" as used hereinafter is
intended
to refer to the detection of an obstruction of an aspiration probe, caused by
an internal clot
in the probe, an external clot in the aspiration path outside the probe or any
other
obstruction that is internal or external of the probe that serves to reduce
the amount or flow
rate of fluid being aspirated in a predetermined time period.
Clot detection problems arise when an aspirated sample volume is relatively
small
such as for example approximately one to seven microliters. Aspiration of a
one to seven
microliter sample can be accomplished with a relatively small amount of vacuum
in the
range of one centimeter of water. However transducer measurement of a vacuum
level of
one centimeter of water is difficult to recognize because even a sensitive
transducer has a
3
CA 02273514 1999-06-02
noise level that is likely to obscure the detection or measurement of a vacuum
level of one
centimeter of water.
At vacuum levels in the range of one centimeter of water the transducer noise
level
also obscures the recognition of deviant vacuum levels that may indicate an
obstructed
S aspiration. Thus far it is not feasible to rely on transducer based vacuum
measurement for
clot detection when aspirating samples of one to seven microliters.
It is therefore desirable to provide a method and apparatus for clot detection
at an
aspiration probe when the aspirated volumes are of the order of one to seven
microliters
and the vacuum levels are in the range of one centimeter of water.
OBJECTS AND SUMMARY OF THE INVENTION
Among the several objects of the invention may be noted the provision of a
novel
method of a blood clot detection during aspiration of a blood or serum sample,
a novel
method of blood clot detection during aspiration of one to seven microliters
of blood or
serum sample, a novel method of blood clot detection for aspiration systems
that develop a
vacuum in the range of one centimeter of water, a novel method of blood clot
detection
which is applicable to an analytical line that receives a sequence of spaced
samples that are
advanced in the analytical line by a continuing succession of samples, a novel
method of
distinguishing test samples that are acceptable for test purposes and test
samples that are
unacceptable for test purposes in a sample analysis system, a novel method of
segregating
an unacceptable aspirated test sample from a continuous flow of acceptable
test samples,
and a novel sampling system that provides selective isolation of an
unacceptable test
sample from an aggregation of acceptable test samples and selective joining of
an
acceptable test sample with other acceptable test samples.
4
CA 02273514 1999-06-02
Other objects and features of the invention will be in part apparent and in
part
pointed out hereinafter.
In accordance with the invention a sampling system includes an aspiration line
having an aspiration pump in series with an aspiration probe. The sampling
system further
includes an analytical line having a reading station that is normally in
communication with
a stream pump. A valve having a vent outlet is disposed across the aspiration
line and the
analytical line and has a first valve position that prevents communication
between the
aspiration line and the analytical line. The first valve position also permits
communication
between the aspiration pump and the aspiration probe and also permits
communication
between the stream pump and the analytical line. The valve has a second valve
position
that prevents communication between the aspiration pump and the aspiration
probe while
permitting communication between the aspiration pump and the analytical line.
The
second valve position also enables the stream pump to vent through a valve
vent.
A transducer is disposed on the aspiration line between the aspiration pump
and the
valve to detect pressure at the aspiration probe during aspiration of fluid.
When a test
sample is aspirated the valve is in the first valve position and the
transducer provides
output voltage readings at predetermined time intervals during the aspiration
cycle that
correspond to the vacuum level in the aspiration probe during aspiration. A
microprocessor connected to the pressure transducer converts the voltage
readings to
pressure readings and integrates the pressure readings over time to provide a
pressure
integral for each aspiration.
5
CA 02273514 1999-06-02
A baseline or reference pressure integral is also developed for a known
unclotted
aspiration. The reference pressure integral is compared with each test sample
aspiration
pressure integral.
When the pressure integral for a test sample differs from the reference
pressure
integral by an amount greater than three standard deviations of the reference
pressure
integral it can be determined that the test sample aspiration was impeded by a
blood clot
and would not provide a reliable evaluation at the sampling system reading
station.
The discrepant test sample aspiration is thus unacceptable for test purposes
and is
kept isolated from the analytical line when the valve is in the first valve
position. The
unacceptable test sample aspiration can also be removed from the aspiration
line while the
valve is in the first valve position. In addition the aspiration probe can be
cleaned or
replaced while the valve is in the f rst valve position since the first valve
position isolates
the analytical line from the aspiration line, and permits continuous flow of
test samples in
the analytical line by operation of the stream pump.
If the difference between the test sample aspiration pressure integral and the
reference pressure integral is less than three standard deviations of the
reference pressure
integral the test sample is considered acceptable for test purposes and the
valve is
positioned in the second valve position.
With the valve in the second valve position, communication is provided between
the aspiration line the analytical line and the aspiration pump. The
aspiration pump is
operated in a reverse direction to transfer the acceptable aspirated test
sample from the
aspiration line into the analytical line to join the other test samples in the
analytical line as
they move toward the reading station.
6
CA 02273514 1999-06-02
The invention also includes a method of detecting a blood clot or other
obstruction
while aspirating a test sample. The method requires aspirating a first
predetermined
volume of reference serum that is free of clots and obstructions across a
probe opening of
predetermined size and measuring the time duration of such reference serum
aspiration.
The vacuum level versus time of the reference serum aspiration is measured
during the
time duration of the reference serum aspiration. An integration is performed
of the vacuum
level versus time for a selected predetermined time duration during the
measured time
duration to establish a reference integral for the reference serum aspiration.
A test serum is
aspirated across the same probe opening of predetermined size during the
measured time
duration. The vacuum level of the test sample aspiration is measured versus
time and an
integration is performed of the vacuum level versus time for the test serum
aspiration
during the selected predetermined time duration to establish a test sample
integral for the
test serum aspiration.
The reference integral is used as a basis of comparison with the test sample
integral
to determine what difference if any exists between the test sample integral
and the
reference integral. If such difference exceeds a predetermined amount it is
determined that
a clot or other obstruction influenced the test serum aspiration and such
aspiration is
unacceptable for test purposes. The unacceptable test sample is prevented from
entering an
analytical line of a sample analysis system.
The invention also includes a method of segregating an unacceptable aspirated
test
sample from a continuous flow of acceptable test samples. The method includes
providing
an aspiration line with an aspiration probe, and an analytical line which
conveys test
samples to a reading station. An aspiration pump is provided in series with
the aspiration
7
CA 02273514 1999-06-02
probe on the aspiration line and a stream pump is provided in series with the
reading
station of the analytical line. A flow control device, such as a valve is
provided across the
aspiration line and the analytical line to optionally keep the flow in the
analytical line
separate from the flow of the aspiration line. The vacuum level of an
aspirated test sample
is measured to determine whether the aspirated test sample is acceptable or
unacceptable.
If the test sample is unacceptable the separate flow option is maintained to
prevent the
unacceptable test sample from entering the analytical line. If the test sample
is acceptable,
communication is established between the aspiration line and the analytical
line to permit
entry of the acceptable test sample into the analytical line.
The invention accordingly comprises the constructions and methods hereinafter
described, the scope of the invention being indicated in the claims.
DESCRIPTION OF THE DRAWINGS
In the drawings,
Fig. 1 is a simplified schematic view of an aspiration system with a blood
clot
detection system incorporating one embodiment of the present invention, the
aspiration
system being in an aspiration mode;
Fig. 2 is a view similar to Fig. 1 with the aspiration system in a non-
aspiration
mode;
Fig. 3 is a vacuum trace for aspiration of unclotted plasma based on a plot of
transducer voltage versus time; and,
Fig. 4 is a vacuum trace made under similar conditions as in Fig. 3 for
aspiration of
clotted plasma.
8
CA 02273514 1999-06-02
Corresponding reference characters indicate corresponding parts throughout the
several views of the drawings.
DETAILED DESCRIPTION OF THE INVENTION
Referring to Figs. 1 and 2 of the drawings, a sampling system that
incorporates one
embodiment of the invention is generally indicated by the reference number 10.
The sampling system 10 includes an aspiration probe 12 supported by a suitable
known moveable probe arm 14. The probe arm 14 positions the probe 12 to enter
an oil
reservoir 16, a reagent or buffer container 18 or a sample tube 19 for
aspiration purposes.
A conduit section 20, also referred to as an aspiration line, connects the
aspiration probe 12
to a known valve 26 such as a shear valve with a vent 28. A conduit section
30, also
referred as an aspiration line, is connected at one end to the valve 26 and is
connected at an
opposite end to an aspiration pump 30 such as a suitable known syringe pump.
A pressure transducer 40 is connected to the aspiration line 30 to measure the
vacuum level in the aspiration line during aspiration of a test sample 80 by
the probe 12.
1 S The test sample 80 is also referred to as a test capsule and includes test
sample from the
sample tube 19 and reagent from the container 18. All further discussion of
test sample
aspiration unless otherwise indicated relates solely to the aspiration of
liquid from the
sample tube 19. The transducer 40 is preferably a Sensym Model SXOSDN, with a
range
of 0-S psi, sold by Sensym Company of Milpitas, California or comparable
equivalent
device. The transducer 40 is connected to a suitable known microprocessor 42
and the
microprocessor is connected to a suitable known warning device 44 such as a
visual or
sound alarm.
9
CA 02273514 1999-06-02
The sampling system 10 further includes a conduit section S0, also referred to
as an
analytical line, having one end connected to the valve 26 and an opposite end
is directed to
a known sample analysis reading station 52. A conduit section 60, also
referred to as a
stream line, is connected at one end to the valve 26 and is connected at an
opposite end to a
suitable known stream pump 62 that provides an air stream.
During test sampling, the valve 26 is in a first valve position as shown in
Fig. 1 to
permit communication between the aspiration line 20 and the aspiration line
30. The first
valve position of the valve 26 also permits communication between the
analytical line 50
and the stream line 60 but prevents communication between the aspiration lines
20, 30 and
the analytical and stream lines 50, 60. In the first valve position of the
valve 26 there is
also no communication between the valve vent 28 and the aspiration, analytical
and stream
lines 20, 30, S0, 60.
With the valve 26 in the first valve position of Fig. 1 the probe 12 initially
enters
the oil reservoir 16 to aspirate a predetermined amount of oil. The aspirated
oil is drawn
into the aspiration conduits 20 and 30 to the aspiration pump 38. The probe 12
is then
positioned by the probe arm 14 to enter the reagent and buffer container 18
where a
predetermined amount of reagent and buffer is aspirated. The probe 12 is
further
positioned by the probe arm 14 to enter the sample tube 19 to aspirate serum
or test
sample. Serum is aspirated for a predetermined time duration that corresponds
to the
withdrawal of a predetermined volume of test sample from the sample tube 19
into the
probe 12.
Using a suitable known probe or pipette 12 and a suitable known syringe pump
38,
a 1.1 microliter of test sample can be aspirated in a predetermined time such
as
CA 02273514 1999-06-02
approximately 300 milliseconds. Just before aspiration begins the pressure
transducer 42
initially measures the pressure with the probe 12 immersed in the liquid of
the sample tube
19. The initial transducer measurement represents drift in the transducer
signal due to
outside temperature and other ambient factors. The transducer 42 then measures
the
pressure during aspiration at predetermined time intervals such as
approximately 5
millisecond intervals until the aspiration is completed. The transducer
measurement is in
the form of an output voltage V that corresponds to the aspiration vacuum. The
output
voltage of the transducer 40 at the predetermined time intervals are stored in
the
microprocessor 42.
Referring to Fig. 3 a vacuum trace of a 1.1 microliter aspiration of test
serum that is
free of blood clots or other obstructions is also referred to as a reference
trace. The
vacuum trace of Fig. 3 is based on output voltage of the transducer 40 plotted
according to
time T in milliseconds over an aspiration cycle of approximately 300
milliseconds. ~ It can
be seen from the reference trace of Fig. 3 that the aspiration cycle is
characterized by an
1 S abrupt increase in vacuum, or decrease in pressure when fluid begins to
enter the probe as
indicated at points D to E on the trace. The vacuum gradually decreases from
point E to
point F as aspiration is completed resulting in a relatively smooth curve G
that rises toward
the zero axis of the vacuum trace.
Each test sample aspiration is conducted over the same predetermined time
period
using the same probe or pipette 12 and the same aspiration pump 38 that is
used to produce
the reference trace of Fig. 3. When a blood clot or other obstruction impedes
the aspiration
flow of test sample into the probe 12 it becomes imperative to detect such
obstruction in
11
CA 02273514 1999-06-02
order to ensure that reliable test results are obtained at the reading station
52 of the sample
analysis system.
The vacuum trace for a clot impeded aspiration is shown in Fig. 4 and was made
under the same conditions and with the same parameters used in the aspiration
represented
by the vacuum trace of Fig. 3.
It will be noted that the range of the transducer output voltage during each
vacuum
trace of Figs. 3 and 4 is approximately the same except that there is a
different duration of
voltage or vacuum levels during the respective aspiration cycles. Generally,
no single
voltage or vacuum level distinguishes a clotted aspiration condition from an
unclotted
aspiration condition at the low levels of vacuum that are applied for a 1.1
microliter
aspiration. The clot impeded vacuum trace of Fig. 4 is characterized by a
prolonged,
relatively high vacuum level between points J and K of the time cycle whereas
the
corresponding points J and K of the time cycle for the unclotted aspiration
vacuum trace of
Fig. 3 show a gradual decrease of vacuum level.
1 S It can also be noted from the vacuum traces of Figs. 3 and 4 that the area
between
the negative portion G of the vacuum trace and the zero axis in Figs. 3 and 4
is noticeably
different.
Applicants have found that by integrating the transducer output voltage levels
versus time for select time intervals during each aspiration cycle, such as
between E and F
an area measurement is obtained that provides an easily recognizable
quantitative
distinction between the Fig. 3 vacuum trace for an unclotted aspiration and
the Fig. 4
vacuum trace for a clotted aspiration. Integration of the transducer output
voltage over
time also serves a noise reduction function. By adding up the time intervals
for which the
12
CA 02273514 1999-06-02
vacuum is relatively strong with the time intervals for which the vacuum is
relatively weak,
the net result is proportional to the average vacuum. Therefore, an
integration operation
does not suffer the shortcomings of instantaneous voltage measurements that
are obscured
by the transducer noise that generally occurs at the relatively low vacuum
levels used for
aspirating 1.1 microliters of test sample.
In order to obtain the integral measurements that facilitate distinction
between a
clotted aspiration and an unclotted aspiration, the output voltage
measurements of the
pressure transducer are stored in the computer memory of the microprocessor 42
and are
converted into pressure values using the known calibration curve of the
pressure transducer
40. During or immediately after an aspiration time cycle is completed the
microprocessor
calculates a vacuum integral from the converted pressure values. The vacuum
integral is
hereinafter referred to as a pressure integral (PI).
The integration process is essentially a process wherein each vacuum value at
5
millisecond intervals, for example, is multiplied with the corresponding time
interval over
which the vacuum value is measured to obtain a multiplication result, and
these
multiplication results are added together for a given time duration to obtain
the integral
value. The integration is preferably made during the time intervals from
points E to F in
Figs. 3 and 4 when the vacuum trace follows a path below the zero axis which
provides the
area of greatest distinction between the clotted and unclotted vacuum traces.
This time
interval from points E to ~ of the aspiration time cycle in Figs. 3 and 4 is a
shorter time
duration than the time duration of the overall aspiration cycle.
13
CA 02273514 1999-06-02
The pressure integral (PI) for an aspiration is calculated using the following
formula:
PI = E [Px*dt- n E (p~*dt)~
K--l j=1
where,
pk = pressure value measured during the aspiration,
S m = number of measured pressure values pk,
p~ = pressure value measured with the probe immersed in liquid but
before the aspiration starts, and
n = number of measured pressure values p~.
Once the pressure integral (PI) for a known unclotted test sample aspiration
is
calculated using the pressure integral formula, such integral can be used as a
reference
integral (PI ref). The mean value and standard deviation of such reference
integral cari be
determined using known mathematical procedures. A pressure integral for the
test sample
assays (PI test) is then provided by the microprocessor 42 for each test
sample aspiration.
The microprocessor 42 can be programmed using suitable known programming
techniques to determine the difference between each test sample pressure
integral and the
reference pressure integral (PI test - PI ref). It has been found that when
the pressure
integral difference (PI dif) between the test sample pressure integral and the
reference
pressure integral is greater than three standard deviations of the reference
integral, as where
PI dif > 3 SD or
PI test - PI ref >3 SD
the aspirated test sample will produce flawed test results. A test sample
aspiration that is
characterized by a PI dif > 3 SD is thus unacceptable and when detected should
be
14
CA 02273514 1999-06-02
prevented from passing into the analytical line 50 to the reading station 52.
When PI dif >
3 SD the microprocessor 42 activates the alarm 44 in any suitable known manner
to
provide a visual or sound signal
Reference pressure integrals also referred to as reference integrals can be
obtained
for selected aspiration volumes such as 1 microliter, 2 microliters, 3
microliters and so on.
Using known mathematical techniques the reference integrals can be used to
form a
calibration curve for various selected aspiration volumes in a range, for
example, of 1 to 7
microliters. The calibration curve can then permit interpolation or
extrapolation of
reference integral values for aspiration volumes that are in between or beyond
the
aspiration volumes actually used to form the basis for specific reference
integrals.
The sampling system shown schematically in Figs. 1 and 2 employs continuous
flow capsule chemistry technology of the type shown in U. S. Patent No.
5,268,147, the
disclosure of which is hereby incorporated by reference in this specification.
As previously
noted the term test capsule is used to refer to a test sample and reagent that
are sequentially
aspirated by a probe and form a combined unit in an aspiration line. The terms
test capsule
and aspirated test sample are used interchangeably herein.
In known continuous flow capsule chemistry technology, a stream of segregated
test capsules is fed continuously in an analytical line to a reading station.
As new test
capsules enter the analytical line, the stream of segregated capsules
continuously advances
toward the reading station so that each test capsule can be individually read
or analyzed.
Thus the advancement of test capsules toward the reading station is based on a
continuous
addition of new test capsules to the analytical line.
CA 02273514 1999-06-02
If the addition of new test capsules to the analytical line is suspended, the
test
capsules already in the analytical line are immobilized. When a test capsule
is immobile
the test results for such test capsules can be lost while the test capsules
remain stationary in
the analytical line because a reaction continues to occur between the test
sample and the
reagent that are combined at a predetermined time after aspiration begins. The
test sample
reaction should thus be read at the reading station within a predetermined
time after the test
sample has been aspirated.
In known sampling systems when an aspiration probe is clogged or the
aspiration of
the test sample is obstructed the discrepant sample can be removed from the
aspiration line,
the probe can be cleaned or replaced and the aspiration repeated. Such
remedial operations
usually hold up the continuous flow of test samples or test capsules in the
analytical line.
As previously noted any cessation of test capsule movement in an analytical
line places the
test results at risk of loss.
In the present sampling system if an aspirated sample in the aspiration line
was
impeded by a clot and is unacceptable for analysis, the stream of test
capsules in the
analytical line can still be continuously advanced to a reading station while
the
unacceptable test sample is removed from the system and while the probe is
cleaned or
replaced.
Referring to Fig. 1 the test sample 80 in the aspiration line 20 is subject to
pressure
measurement by the pressure transducer 40 during aspiration of the test sample
80 into the
probe 12. If the difference between the pressure integral of the test sample
80 (PI test) and
the reference integral (PI refj is greater than three standard deviations,
then the test sample
80 is unacceptable for analysis and should not be permitted to enter the
analytical line 80.
16
CA 02273514 1999-06-02
The test sample 80 should thus be removed from the aspiration line 20 or 30
and the probe
12 should be examined to determine whether a cleaning or replacement is
warranted.
When the valve 26 is in the valve position of Fig. 1 such removal of an
unacceptable test sample as well as the cleaning or replacement of the probe
12 can be
accomplished without interfering with the continuous flow of test capsules in
the analytical
line 50. The valve 26 as positioned in Fig. 1 isolates the aspiration line 20,
30 from the
analytical line 50, 60. Such isolation enables the stream pump 62 to provide
an air stream
to the analytical lines 60 and 50, to effect movement of test samples such as
90 in the
analytical line 50 toward the reading station 52.
Stream pump movement of the test sample 90 in the analytical line 50 is
accomplished even when remedial operations are being performed at the
aspiration lines 20
or 30 to remove an unacceptable sample 80 and/or replace or clean the probe 12
and the
analytical line 20. Thus whenever a sample probe 12 becomes incapacitated by
clogging
the probe 12 can be easily cleaned or replaced without stopping the
progression of test
samples such as 90 in the analytical line 50.
If the difference between the pressure integral for the test sample 80 (PI
test) and
the reference integral (PI ref) is less than three standard deviations, the
test sample 80 can
be transferred to the analytical line 50 for movement to the reading station
52. Such
transfer is accomplished by first drawing the test sample 80 (shown dotted) to
a position
beyond valve 26 in the aspiration line 30. The valve 26 is then placed in the
valve position
of Fig. 2 to enable the aspiration line 30 to communicate with the analytical
line 50 and to
vent the stream pump 62 through the valve vent 28.
17
CA 02273514 1999-06-02
With the valve 26 in the valve position of Fig. 2 the aspiration pump 30 is
operated
in a direction indicated by the arrow 39. The test sample 80 and a
predetermined amount
of previously aspirated oil from the container 16 are thus caused to move from
the
aspiration line 30 to the analytical line 50. The transferred oil is used to
separate
consecutive test samples in the analytical line 50 in accordance with known
sampling
system techniques disclosed in U.S. patent 5,268,147. The test sample 80 thus
joins the
continuous stream of test samples such as 90 in the analytical line 50 that
are moving
toward the reading station 52.
After the test sample 80 has been transferred to the analytical line 50 the
valve 26 is
repositioned to the Fig. 1 valve position to prepare the sampling system 10
for aspiration of
another test sample into the probe 12 in a manner similar to that previously
described.
The valve 26 is thus positionable to maintain an aspirated test sample in the
aspiration line 20, 30 in isolation from the analytical line 50, and stream
line 60 (Fig. 1 )
and further positionable to permit transfer of an aspirated test sample from
the aspiration
line 30 to the analytical line 50.
Some advantages of the invention evident from the foregoing description
include a
method of detecting a blood clot or other obstruction while aspirating a test
sample at
relatively low vacuum levels such as 1 centimeter of water. Another advantage
is a method
of furnishing a recognizable distinction between an acceptable test sample and
an
unacceptable test sample whose aspiration was influenced by a blood clot. A
further
advantage is the use of pressure integrals as a basis of comparison between
the vacuum
characteristics of an acceptable test sample and an unacceptable test sample.
The pressure
integral serves as a noise reduction function that enables transducer output
voltage at low
18
CA 02273514 1999-06-02
level vacuum measurements to be formatted in a manner that permits distinction
between
the vacuum trace of an acceptable test sample and the vacuum trace of an
unacceptable test
sample influenced by a blood clot or other obstruction. Still another
advantage is the
provision of a sampling system wherein an aspiration line and an analytical
line can be
selectively maintained in isolation from each other when such isolation is
desired and
communicated with each other when such communication is desired. Selective
communication between the aspiration line and the analytical line ensures a
continuous
flow of samples in an analytical line even when remediation procedures are
being
performed at the aspiration line.
In view of the above it will be seen that the several objects of the invention
are
achieved and other advantageous results obtained. As various changes can be
made in the
above constructions and methods without departing from the scope of the
invention it is
intended that all matter contained in the above description or shown in the
accompanying
drawings shall be interpreted as illustrative and not in a limiting sense.
19
